Onyx Biotec Chart
Onyx Biotec Share Key Metrics
Volume
24000.00
Market Cap
51.95 CR
LTQ@LTP
2000@29.80
ATP
28.13
Var Margin
53.5 %
Circuit Range
22.95-34.35
Delivery %
85.71 %
Value
6.75 L
ASM/GSM
No
Market Lot
2000
Summary
Onyx Biotec Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
71.49
Sector P/B
3.47
Sec. Div. Yield
0.55
Onyx Biotec Resistance and Support
Pivot 28.7
Resistance
First Resistance
30.9
Second Resistance
33.15
Third Resistance
35.35
Support
First Support
26.45
Second Support
24.25
Third Support
22
Onyx Biotec Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-14 | Audited Results |
Onyx Biotec News
Onyx Biotec Limited
Onyx Biotec's Board of Directors will convene on May 14, 2026, to consider and approve the audited standalone financial results for the fiscal year ended March 31, 2026. This meeting will finalize the company's full year financial performance.
May 07 2026 13:05:00
Onyx Biotec Limited
Onyx Biotec's Board of Directors is scheduled to meet on May 14, 2026. The primary agenda includes considering and approving the audited financial results for the half and financial year ended March 31, 2026.
May 07 2026 13:05:00
About Onyx Biotec AboutThe
NSE : 27136
BSE : 0
ISIN : INE0WVU01018
Our Company was incorporated on May 13 2005 as a private limited company as ‘Onyx Biotec Private Limited’ under the Companies Act 1956 pursuant to a certificate of incorporation dated May 13 2005 issued by the Registrar of Companies Punjab H.P. & Chandigarh. Further our Company was converted into a public limited company pursuant to a resolution passed by our Board of Directors in its meeting held on May 1 2024 and by the Shareholders in an Extraordinary General Meeting held on May 27 2024 and consequently the name of our Company was changed to ‘Onyx Biotec Limited’ and a fresh certificate of incorporation dated July 23 2024 was issued by the Registrar of Companies Central Processing Centre. The corporate identification number of our Company is U24230HP2005PLC028403.Major Events and Milestones:2010-Our Company commenced commercial production at our Unit I with two line of Form Fill and Seal setup with capacity of 2 lacs units per day2017-Capacity expansion at our Unit I from 130 million unit per annum to 230 million units per annum-Our Company received a certificate for Good Manufacturing Practice from Deputy Drugs Controller cum Licensing Authority Health & Family2023-Our Company commenced commercial production at our Unit II
Onyx Biotec Management
| Name | Position |
|---|---|
| Sanjay Jain | Managing Director |
| Naresh Kumar | Whole Time Director |
Onyx Biotec Similar Stocks
Onyx Biotec FAQs
